Share of drug costs by type in public drug plans Canada 2014/15 to 2021/22

Patented drugs made up some 52 percent of all drug costs in select Canadian public drug plans in fiscal year 2021/2022, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Yukon, and the Non-Insured Health Benefits Program.

在2021/2022财政年度，加拿大部分公立药品计划中，包括不列颠哥伦比亚省、艾伯塔省、萨斯喀彻温省、马尼托巴省、安大略省、新不伦瑞克省、新斯科舍省、爱德华王子岛省、纽芬兰和拉布拉多省、育空地区以及非保险医疗福利计划，专利药品占据了全部药品费用的约52%。